{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:17:02Z","timestamp":1790223422077,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejca.2018.06.013","type":"journal-article","created":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T15:55:52Z","timestamp":1531583752000},"page":"278-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Developments in the understanding of blood involvement and stage in mycosis fungoides\/Sezary syndrome"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8011-4408","authenticated-orcid":false,"given":"Julia J.","family":"Scarisbrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmilia","family":"Hodak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Bagot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1882-4908","authenticated-orcid":false,"given":"Rene","family":"Stranzenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo L.","family":"Ortiz-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Papadavid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Knobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Quaglino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Vermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2018.06.013_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejca.2018.01.076","article-title":"Blood classification and blood response criteria in mycosis fungoides (MF) and S\u00e9zary syndrome (SS) using flow cytometry: recommendations from the EORTC Cutaneous Lymphoma Task Force","volume":"93","author":"Scarisbrick","year":"2018","journal-title":"Eur J Canc"},{"issue":"5","key":"10.1016\/j.ejca.2018.06.013_bib2","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.jid.2018.03.550","article-title":"Changes in blood involvement in Sezary syndrome positively correlate with skin severity but not in mycosis fungoides","volume":"138","author":"Wernham","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"32","key":"10.1016\/j.ejca.2018.06.013_bib3","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","article-title":"Cutaneous lymphoma international consortium (CLIC) Study of outcome in advanced stages of mycosis fungoides & S\u00e9zary syndrome: effect of specific prognostic markers on survival and development of a prognostic model","volume":"33","author":"Scarisbrick","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2018.06.013_bib4","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood.V97.3.624","article-title":"Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma","volume":"97","author":"Scarisbrick","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejca.2018.06.013_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-4632.2009.03771.x","article-title":"Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma","volume":"48","author":"Vidulich","year":"2009","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.ejca.2018.06.013_bib6","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1080\/10428190600709655","article-title":"S\u00e9zary cell counts in erythrodermic cutaneous T-celllymphoma: implications for prognosis and staging","volume":"47","author":"Vonderheid","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.ejca.2018.06.013_bib7","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.jid.2018.03.524","article-title":"Global collaboration for establishment of a prognostic index in mycosis fungoides & Sezary syndrome","volume":"138","author":"Quaglino","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.ejca.2018.06.013_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP1NA3YCHCDEIG","article-title":"Blood flow cytometry in S\u00e9zary syndrome: new insights on prognostic relevance and immunophenotypic changes during follow-up","volume":"43","author":"Novelli","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.ejca.2018.06.013_bib9","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jid.2016.01.038","article-title":"Evaluation of immunophenotypic and molecular biomarkers for S\u00e9zary syndrome using standard operating procedures: a multicenter study of 59 patients","volume":"136","author":"Boonk","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"14","key":"10.1016\/j.ejca.2018.06.013_bib10","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1158\/1078-0432.CCR-16-3185","article-title":"Usefulness of KIR3DL2 to diagnose, follow-up, and manage the treatment of patients with S\u00e9zary syndrome","volume":"23","author":"Hurabielle","year":"2017","journal-title":"Clin Canc Res"},{"issue":"6","key":"10.1016\/j.ejca.2018.06.013_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.14850","article-title":"Lymph node image-guided core-needle biopsy for cutaneous T-cell lymphoma staging","volume":"175","author":"Battistella","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2018.06.013_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6890-2-5","article-title":"A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy","volume":"2","author":"Washington","year":"2002","journal-title":"BMC Clin Pathol"},{"key":"10.1016\/j.ejca.2018.06.013_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2340\/00015555-2264","article-title":"Expression of CD164 on malignant T cells in S\u00e9zary syndrome","volume":"96","author":"Guenova","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.ejca.2018.06.013_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.leu.2404481","article-title":"Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies report of the BIOMED-2 concerted action BHM4 CT98-3936","volume":"21","author":"Br\u00fcggemann","year":"2007","journal-title":"Leukemia"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804918309055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804918309055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T19:59:36Z","timestamp":1539115176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804918309055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":14,"alternative-id":["S0959804918309055"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2018.06.013","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developments in the understanding of blood involvement and stage in mycosis fungoides\/Sezary syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2018.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2018.06.019","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2018.01.076","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}